Global Vitiligo Foundation Listing.
For Vitiligo patients age 12 years and older,
This is Incyte trial for Ruxolitinib cream and is recommended for those with less than 10% vitiligo on the body.
https://clinicaltrials.gov/ct2/show/NCT04052425
Vitiligo Clinic and Research Center - Dr. John Harris